ERIS latest shareholding pattern: promoter holding, FII / FPI holding, DII and mutual fund holding, public holding and number of shareholders, quarter by quarter.
As of Sep 2026, promoters held 54.74% of Eris Lifesciences Ltd, FIIs 5.74%, DIIs 20.19%, government - and the public 19.32%, across 49,034 shareholders.